MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 48 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,113 | -67.0% | 162,410 | 0.0% | 0.01% | -66.7% |
Q2 2023 | $64,071 | -16.1% | 162,410 | 0.0% | 0.03% | -21.1% |
Q1 2023 | $76,333 | -6.0% | 162,410 | 0.0% | 0.04% | -9.5% |
Q4 2022 | $81,205 | -21.2% | 162,410 | 0.0% | 0.04% | -28.8% |
Q3 2022 | $103,000 | -8.8% | 162,410 | +14.0% | 0.06% | -4.8% |
Q2 2022 | $113,000 | -1.7% | 142,410 | 0.0% | 0.06% | +12.7% |
Q1 2022 | $115,000 | -29.4% | 142,410 | -11.6% | 0.06% | -23.6% |
Q4 2021 | $163,000 | -24.2% | 161,160 | -2.4% | 0.07% | -26.5% |
Q3 2021 | $215,000 | +45.3% | 165,160 | -13.6% | 0.10% | +60.7% |
Q2 2021 | $148,000 | -31.5% | 191,160 | +20.5% | 0.06% | -41.9% |
Q4 2020 | $216,000 | +66.2% | 158,660 | -6.2% | 0.10% | +31.2% |
Q3 2020 | $130,000 | +16.1% | 169,160 | +16.7% | 0.08% | +1.3% |
Q2 2020 | $112,000 | +86.7% | 145,000 | +45.0% | 0.08% | +43.6% |
Q1 2020 | $60,000 | -73.6% | 100,000 | 0.0% | 0.06% | -67.8% |
Q4 2019 | $227,000 | – | 100,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |